Synthesis and biological activity of mustard derivatives of thymine

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 5, 2008, Pages 439-448

  Hadj Bouazza, Amel ^a   Teste, Karine ^a   Colombeau, Ludovic ^a   Chaleix, Vincent ^a   Zerrouki, Rachida ^a   Kraemer, Michel ^b   Catherine, Odile Sainte ^b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Anticancer; DNA cross linking; Microwave; Nitrogen mustards; Thymine

Indexed keywords

1 ETHOXYCARBONYLMETHYLTHYMINE; 1,3 DI (1 ETHOXYCARBONYLMETHYL)THYMINE; ANTINEOPLASTIC AGENT; N,N DI (2 CHLOROETHYL) 2 (THYMIN 1 YL)ACETAMIDE; THYMINE DERIVATIVE;

ALKYLATION; ARTICLE; BIOLOGICAL ACTIVITY; BRASSICA; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; VULVA CARCINOMA;

ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTAXIS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NITROGEN MUSTARD COMPOUNDS; THYMINE;

BRASSICACEAE;

EID: 45849131334     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802086872     Document Type: Article

References (19)

1. Chabner, B.A.; Longo, D.L. Cancer Chemotherapy and Biotherapy: Principles and Pratice; Lippincott-Raven: Philadelphia, 1996.
2. Hartley, J.A.Selectivity in Alkylating Agent-DNA Interactions In Molecular Aspects of Anti-cancer Drug-DNA Interactions; eds. Neidle, S.; Waring M.J.; Macmillan, New York, 1993, pp. 1-31.
3. Sunters, A.; Springer, C.J.; Bagshawe, K.D.; Souhami, R.L.; Hartley, J.A. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid. Biochem. Pharmacol. 1992, 44, 59-64.
4. Cruickshank, K.A.; Jiricny, J.; Reese, C.B. The benzoylation of uracil and thymine, Tetrahedron Lett., 1984, 25, 681-684.
5. Malik, V.; Singh, P.; Kumar, S. Regioselective synthesis of 1-allyl- and 1-arylmethyl uracyl and thymine derivatives. Tetrahedron, 2005, 61, 4009-4014.
6. a) Brown, D.T.; Eisingerand, F.J.; Leonard, N.J. Synthetic spectroscopic models related to coenzymes and base pairs. II. Evidence for intramolecular base-base interactions in dinucleotide analogs. J. Am. Chem. Soc., 1968, 90, 7302-7323;
7. b) Sazaki, T.; Minamoto, V.; Susuki, T.; Yamashita, S. Search for a simpler synthetic model system for intramolecular 1,3-dipolar cycloaddition to the 5,6-double bond of a pyrimidine nucleoside. Tetrahedron, 1980, 36, 865-870;
8. c) Abdel-Megied, A.E.S.; Motawia, M.S.; Pedersen, E.B.; Nielsen, C.M. 5-Alkoxymethyl-1-hydroxyalkyluracils with potential anti-HIV activity. Heterocycles, 1992, 34, 713-722;
9. d) Grandjean, P.; Benhaddou, R.; Granet, R.; Krausz, P.A. Unexpected result in the alkylation of thymine. Tetrahedron Lett., 1997, 38, 6185-6188.
10. Perreux, L.; Loupy, A. A tentative rationalization of microwave effects in organic synthesis according to the reaction medium, and mechanistic considerations. Tetrahedron, 2001, 57, 9199-9223.
11. a) Di Benedetto, M.; Starzec, A.; Vassy, R.; Perret, G.Y.; Crepin, M.; Kraemer, M. Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. Br. J. Cancer. 2003, 88, 1987-1994;
12. b) Guenin, E.; Ledoux, D.; Oudar, O.; Lecouvey, M.; Kraemer, M. Structure-activity relationships of a new class of aromatic bisphosphonates that inhibit tumor cell proliferation in vitro. Anticancer Res. 2005, 25, 1139-1145;
13. c) Hamma-Kourbali, Y.; Di Benedetto, M.; Ledoux, D.; Oudar, O.; Leroux, Y.; Lecouvey, M.; Kraemer, M. A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis. Biochem. Biophys. Res. Commun. 2003, 310, 816-823.
14. Myoken, Y.; Kayada, Y.; Okamoto, T.; Kan, M.; Sato, G.H.; Sato, J.D. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad. Sci. U S A. 1991, 88, 5819-5823.
15. Melnyk, O.; Shuman, M.A.; Kim, K.J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 1996, 56, 921-924.
16. Malliri, A; Symons, M.; Hennigan, R.F.; Hurlstone, A.F.; Lamb, R.F.; Wheeler, T.; Ozanne, B.W. The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J. Cell Biol. 1998, 143, 1087-1099.
17. Mori, A.; Shigeki, A.; Furutani, M.; Hanaki, K.; Tadeka, Y.; Moriga, T.; Kondo, Y.; Gorin Rivas, M.J.; Imamura, M. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model. Int. J. Cancer. 1999, 80, 738-743.
18. Heissig, B.; Hattori, K.; Friedrich, M.; Rafii, S; Werb, Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr. Opin. Hematol. 2003, 10, 136-141.
19. Neaud, V.; Faouzi, S.; Guirouilh, J.; Le Bail, B.; Balabaud, C.; Bioulac-Sage, P.; Rosenbaum, J. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. J. Hepatology 1997, 26, 1458-1466.